Usage Examples
- Release testing runs the compendial method, so the batch record cites the method and its reference instead of an internal validation report.
- We changed the mobile phase to handle our matrix, so it is no longer the compendial method and needs its own accuracy and reproducibility data.
- QC verified the compendial method under actual conditions of use before the first GMP batch, and filed the suitability data with the method statement.
What is Compendial Method?
Compendial Method is an analytical procedure published in an official pharmacopoeia such as USP-NF that a manufacturer may cite by reference instead of documenting its own accuracy and reliability data. Suitability still must be verified in the using laboratory.
Compendial methods exist so that one published specification can be enforced the same way by every firm testing the same article. FDA's CGMP rules require laboratory records to hold complete data from all tests necessary to assure compliance with established specifications and standards, and a procedure printed in a public compendium gives the regulator and the manufacturer the same test rather than two arguable ones.
Compendial methods cover the test procedure itself, and 21 CFR 211.194(a)(2) treats a method in the current revision of the United States Pharmacopeia, National Formulary, AOAC INTERNATIONAL Book of Methods, or another recognized standard reference as citable by name alone. Outside that scope sit any modified version of the method, any in-house procedure, and the separate, non-waivable obligation to show the method performs in your own laboratory.
Compendial methods appear in practice as a line in the specification and a one-line statement in the laboratory record naming the method and its reference. What remains is suitability verification under actual conditions of use: your analysts, your instruments, your reagents, your matrix. Change the procedure and the naming shortcut disappears, and the accuracy, sensitivity, specificity, and reproducibility evidence becomes yours to generate.
Not to be confused with
- Method validation
- validation generates the accuracy, sensitivity, specificity, and reproducibility record for a method your firm employs. A compendial method carries that burden already discharged by the pharmacopoeia, leaving only verification of suitability in your laboratory.
- Monograph
- a monograph is the whole public standard for an article, including its specification and acceptance criteria. The compendial method is only the test procedure inside the monograph, not the number the result is judged against.
- Alternative (non-compendial) method
- an alternative method is any procedure not in a recognized standard reference, including a compendial method you modified. The CFR shortcut of naming the method and reference stops applying, and the record must point to the supporting data.
- Specification
- a specification states the acceptance criterion the batch must meet. The compendial method is how the result being compared to that criterion is produced; a firm can hold a compendial specification and run a non-compendial method against it.
Compendial method use is governed by the CGMP laboratory-record and release rules, not by a separate compendial regulation.
What you must do
- 1Record complete data from all tests necessary to assure compliance with established specifications and standards21 CFR 211.194(a)
- 2State each method used, and where that method is in the current revision of the USP, National Formulary, AOAC INTERNATIONAL Book of Methods, or another recognized standard reference and is not modified, record the method and reference in place of a data location21 CFR 211.194(a)(2)
- 3Verify the suitability of all testing methods under actual conditions of use, compendial methods included21 CFR 211.194(a)(2)
- 4Establish and document accuracy, sensitivity, specificity, and reproducibility for test methods the firm employs, which is where every modified or non-compendial method lands21 CFR 211.165(e)
- 5Release each batch only after laboratory determination of satisfactory conformance to final specifications, including identity and strength of each active ingredient21 CFR 211.165(a)
Common mistakes
Treating "it is a USP method" as proof the method works in your lab
21 CFR 211.194(a)(2) shortcuts the record, not the science; the same paragraph states that the suitability of all testing methods used shall be verified under actual conditions of use. Firms that skip verification have no defence when a result is challenged in an OOS investigation.
Modifying the method and keeping the compendial citation
the CFR carve-out applies only when the referenced method is not modified. Change the column, the mobile phase, the sample preparation, or the detection wavelength and the batch record must instead point to data establishing accuracy and reliability for the product tested, plus the 21 CFR 211.165(e) package.
Citing a superseded revision
the carve-out names the current revision of the compendium. Specifications frozen at approval and never re-checked leave laboratory records citing a method version that is no longer current, so the shortcut the record depends on no longer covers it.
When This Matters
- Release testing runs the compendial method, so the batch record cites the method and its reference instead of an internal validation report.
- We changed the mobile phase to handle our matrix, so it is no longer the compendial method and needs its own accuracy and reproducibility data.
- QC verified the compendial method under actual conditions of use before the first GMP batch, and filed the suitability data with the method statement.
Frequently Asked Questions
Compendial methods do not need a full in-house validation package, but their suitability must be verified under actual conditions of use. If the method is in the current revision of the USP, National Formulary, or another recognized standard reference and is not modified, the laboratory record only needs a statement naming the method and reference.
Related Use Cases
- Pharma Use Cases
Cut NDA and sNDA prep time by 60% with AI-assisted drafting and automated readiness checks
- Biotech Use Cases
Compress IND prep from 8-12 weeks to under 3 weeks with AI-assisted drafting and validation
- CMC Workflows
Track ICH quality guidelines automatically and get alerts when changes impact your products
- Quality/QA Workflows
Track GxP regulation changes and enforcement trends
